Viewing Study NCT06027892


Ignite Creation Date: 2025-12-24 @ 3:58 PM
Ignite Modification Date: 2025-12-29 @ 9:48 AM
Study NCT ID: NCT06027892
Status: RECRUITING
Last Update Posted: 2024-11-15
First Post: 2023-08-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer
Sponsor: Rabin Medical Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-12-29
Start Date Type: ACTUAL
Primary Completion Date: 2027-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2032-12
Completion Date Type: ESTIMATED
First Submit Date: 2023-08-31
First Submit QC Date: None
Study First Post Date: 2023-09-07
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-11-13
Last Update Post Date: 2024-11-15
Last Update Post Date Type: ACTUAL